Stock Market News

GSK to acquire phase III-ready drug efimosfermin for $1.2 billion

May 14, 2025 - 07:28
 0
GSK to acquire phase III-ready drug efimosfermin for $1.2 billion
Read More

Tags:

Previous Article

UK watchdog probes Aviva's proposed acquisition of Direct Line

Next Article

Ferrovial's quarterly core profit rises 19% led by US highways business

Related Posts

Shares lifted by trade deal hopes, dollar holds post-Fed gains

Shares lifted by trade deal hopes, dollar holds post-Fe...

May 8, 2025  0

Microsoft doesn't allow its employees to use China's Deepseek-President

Microsoft doesn't allow its employees to use China's De...

May 8, 2025  0

Tesla, Insulet Surge Among Market Cap Stock Movers on Friday

Tesla, Insulet Surge Among Market Cap Stock Movers on F...

May 9, 2025  0